<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
      version="3.7"
      xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
   <titleInfo>
      <title>Data on plasma tumour and metabolism related proteins’ potential in differentiation of HFpEF-PH from PAH and in prognosis of left heart failure patients with pulmonary hypertension</title>
   </titleInfo>
   <name type="personal" usage="primary">
      <namePart type="given">Salaheldin</namePart>
      <namePart type="family">Ahmed</namePart>
      <nameIdentifier type="orcid">https://orcid.org/0000-0001-7086-6262</nameIdentifier>
      <displayForm>Ahmed, Salaheldin</displayForm>
      <affiliation>Department of Clinical Sciences Lund, Cardiology, Lund University, Lund, Sweden</affiliation>
      <affiliation>The Haemodynamic Lab, The Section for Heart Failure and Valvular Disease, Heart and Lung Medicine, Skåne University Hospital, Lund, Sweden</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Abdulla</namePart>
      <namePart type="family">Ahmed</namePart>
      <displayForm>Ahmed, Abdulla</displayForm>
      <affiliation>Department of Clinical Sciences Lund, Cardiology, Lund University, Lund, Sweden</affiliation>
      <affiliation>The Haemodynamic Lab, The Section for Heart Failure and Valvular Disease, Heart and Lung Medicine, Skåne University Hospital, Lund, Sweden</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Göran</namePart>
      <namePart type="family">Rådegran</namePart>
      <displayForm>Rådegran, Göran</displayForm>
      <affiliation>Department of Clinical Sciences Lund, Cardiology, Lund University, Lund, Sweden</affiliation>
      <affiliation>The Haemodynamic Lab, The Section for Heart Failure and Valvular Disease, Heart and Lung Medicine, Skåne University Hospital, Lund, Sweden</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <typeOfResource>text</typeOfResource>
   <genre>article</genre>
   <originInfo>
      <dateIssued encoding="w3cdtf" keyDate="yes">2022-02</dateIssued>
   </originInfo>
   <language>
      <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
      <languageTerm type="text">English</languageTerm>
   </language>
   <abstract>The data in the current paper constitutes supplementary material to our article entitled “Plasma tumour and metabolism related biomarkers AMBP, LPL and Glyoxalase I differentiate heart failure with preserved ejection fraction with pulmonary hypertension from pulmonary arterial hypertension” Ahmed et al. (2021). The study investigated 69 plasma tumour- and metabolism related proteins in healthy controls (n = 20) and in 115 patients of whom 48 had pulmonary arterial hypertension (PAH; n = 48) and 67 with left heart failure with pulmonary hypertension (LHF-PH) [heart failure with- preserved ejection fraction-PH (HFpEF-PH; n = 31) and reduced ejection fraction-PH (HFrEF-PH; n = 36)]. The haemodynamic data were obtained with right heart catheterization, and clinical data from medical records. The present article describe the plasma levels of tumour- and metabolism related proteins, analyzed with proximity extension assay, along with their uni- and multivariable diagnostic and prognostic potential. High sRAGE levels univariably emerged as a negative prognostic marker in LHF-PH. </abstract>
   <subject>
      <topic>Prognosis</topic>
   </subject>
   <subject>
      <topic>HFpEF</topic>
   </subject>
   <subject>
      <topic>Pulmonary hypertension</topic>
   </subject>
   <subject>
      <topic>Pulmonary hypertension due to left heart disease</topic>
   </subject>
   <subject>
      <topic>PAH</topic>
   </subject>
   <subject>
      <topic>Haemodynamics</topic>
   </subject>
   <subject>
      <topic>Proteomics</topic>
   </subject>
   <subject>
      <topic>Cancer</topic>
   </subject>
   <relatedItem type="host">
      <titleInfo>
         <title>Data in Brief</title>
      </titleInfo>
      <originInfo>
         <publisher>Elsevier Inc.</publisher>
      </originInfo>
      <identifier type="issn">2352-3409</identifier>
      <part>
         <detail type="volume">
            <number>40</number>
            <caption>v.</caption>
         </detail>
         <text type="display-date">February 2022</text>
         <text type="year">2022</text>
         <text type="month">February</text>
         <extent unit="pages">
            <start>107747</start>
         </extent>
      </part>
   </relatedItem>
   <identifier type="doi">10.1016/j.dib.2021.107747</identifier>
   <location>
      <url>http://dx.doi.org/10.1016/j.dib.2021.107747</url>
   </location>
   <identifier type="pii">S2352-3409(21)01022-2</identifier>
   <accessCondition type="use and reproduction"
                    displayLabel="Creative Commons Attribution 4.0 Generic (CC BY 4.0)">
      <program xmlns="https://data.crossref.org/schemas/AccessIndicators.xsd">
         <licence_ref applies_to="reuse" start_date="2021-12-21"/>
         <licence_ref>http://creativecommons.org/licenses/by/4.0/</licence_ref>
      </program>
   </accessCondition>
   <extension>
      <vendorName/>
      <archiveFile/>
      <originalFile>file:/C:/Users/Carlos.Martinez/OneDrive%20-%20USDA/XML_projects/OpenAccess/OpenAccess/transform/source/sourcefiles/576450669703096969-00001/2352-3409/S2352340921X00078/S2352340921010222/S2352340921010222.xml</originalFile>
      <workingDirectory>C:\Users\Carlos.Martinez\OneDrive - USDA\XML_projects\OpenAccess\OpenAccess\transform\result\</workingDirectory>
   </extension>
</mods>
